TY - JOUR
T1 - Erratum
T2 - Editor's note: Genomic and molecular characterization of malignant peripheral nerve sheath tumor identifies the IGF1R pathway as a primary target for treatment (Clin Cancer Res (2019) 17(7563–7573)Doi:10.1158/1078-0432.CCR-11-1707)
AU - Yang, Jilong
AU - Ylip€a€a, Antti
AU - Sun, Yan
AU - Zheng, Hong
AU - Chen, Kexin
AU - Nykter, Matti
AU - Trent, Jonathan
AU - Ratner, Nancy
AU - Lev, Dina C.
AU - Zhang, Wei
N1 - Publisher Copyright:
© 2019 American Association for Cancer Research.
PY - 2019
Y1 - 2019
N2 - The editors are publishing this note to alert readers to a concern about this article (1): in Fig. 3A, Western blot similarities exist in the EGFR (24, 48, and 72 hours), PI3K (IGF1R siRNA: 24 and 72 hours), pERK (Control siRNA: 48 and 72 hours), and Actin (24 and 72 hours) panels. Original data are not available for review, and the authors stand by the conclusions of the article.
AB - The editors are publishing this note to alert readers to a concern about this article (1): in Fig. 3A, Western blot similarities exist in the EGFR (24, 48, and 72 hours), PI3K (IGF1R siRNA: 24 and 72 hours), pERK (Control siRNA: 48 and 72 hours), and Actin (24 and 72 hours) panels. Original data are not available for review, and the authors stand by the conclusions of the article.
UR - http://www.scopus.com/inward/record.url?scp=85065772427&partnerID=8YFLogxK
U2 - 10.1158/1078-0432.CCR-19-1144
DO - 10.1158/1078-0432.CCR-19-1144
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???
C2 - 31092619
AN - SCOPUS:85065772427
SN - 1078-0432
VL - 25
SP - 3195
JO - Clinical Cancer Research
JF - Clinical Cancer Research
IS - 10
ER -